Literature DB >> 10623645

Gammaherpesviruses and "Hit-and-Run" oncogenesis.

R F Ambinder1.   

Abstract

Mesh：

Year:  2000        PMID： 10623645      PMCID： PMC1868625          DOI： 10.1016/S0002-9440(10)64697-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  39 in total

1.  Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease.

Authors:  L M Weiss; L A Movahed; R A Warnke; J Sklar
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

2.  Epstein-Barr viral DNA in tissues of Hodgkin's disease.

Authors:  L M Weiss; J G Strickler; R A Warnke; D T Purtilo; J Sklar
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

3.  A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.

Authors:  B Sugden; K Marsh; J Yates
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

4.  Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease.

Authors:  T C Wu; R B Mann; P Charache; S D Hayward; S Staal; B C Lambe; R F Ambinder
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

5.  Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.

Authors:  N Mueller; A Evans; N L Harris; G W Comstock; E Jellum; K Magnus; N Orentreich; B F Polk; J Vogelman
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

6.  A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease.

Authors:  S P Staal; R Ambinder; W E Beschorner; G S Hayward; R Mann
Journal:  Am J Clin Pathol       Date:  1989-01       Impact factor: 2.493

7.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.

Authors:  G Pallesen; S J Hamilton-Dutoit; M Rowe; L S Young
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

8.  Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.

Authors:  I Anagnostopoulos; H Herbst; G Niedobitek; H Stein
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

9.  Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association.

Authors:  B Shiramizu; F Barriga; J Neequaye; A Jafri; R Dalla-Favera; A Neri; M Guttierez; P Levine; I Magrath
Journal:  Blood       Date:  1991-04-01       Impact factor: 22.113

10.  Epstein-Barr virus, fatal infectious mononucleosis, and Hodgkin's disease in siblings.

Authors:  R W Veltri; S H Shah; J E McClung; W G Klingberg; P M Sprinkle
Journal:  Cancer       Date:  1983-02-01       Impact factor: 6.860
View more
  38 in total

1.  Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort.

Authors:  Anneclaire J De Roos; Otoniel Martínez-Maza; Keith R Jerome; Dana K Mirick; Kenneth J Kopecky; Margaret M Madeleine; Larry Magpantay; Kerstin L Edlefsen; Andrea Z Lacroix
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-24       Impact factor: 4.254

2.  Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma.

Authors:  Mee Soo Chang; Woo Ho Kim
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

3.  Infection as a cause of childhood leukemia: virus detection employing whole genome sequencing.

Authors:  Christoph Bartenhagen; Ute Fischer; Klaus Korn; Stefan M Pfister; Michael Gombert; Cai Chen; Vera Okpanyi; Julia Hauer; Anna Rinaldi; Jean-Pierre Bourquin; Cornelia Eckert; Jianda Hu; Armin Ensser; Martin Dugas; Arndt Borkhardt
Journal:  Haematologica       Date:  2017-02-02       Impact factor: 9.941

4.  The tumor virus landscape of AIDS-related lymphomas.

Authors:  Aaron Arvey; Akinyemi I Ojesina; Chandra Sekhar Pedamallu; Gianna Ballon; Joonil Jung; Fujiko Duke; Lorenzo Leoncini; Giulia De Falco; Eric Bressman; Wayne Tam; Amy Chadburn; Matthew Meyerson; Ethel Cesarman
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

Review 5.  Post Transplant Lymphoproliferative Disorder.

Authors:  Devika Gupta; Satish Mendonca; Sushmita Chakraborty; Tathagata Chatterjee
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-17       Impact factor: 0.900

6.  Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma.

Authors:  Lynn I Levin; Ellen T Chang; Richard F Ambinder; Evelyne T Lennette; Mark V Rubertone; Risa B Mann; Michael Borowitz; Edward G Weir; Susan L Abbondanzo; Nancy E Mueller
Journal:  Blood       Date:  2012-09-12       Impact factor: 22.113

7.  Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice.

Authors:  Vera L Tarakanova; Felipe Suarez; Scott A Tibbetts; Meagan A Jacoby; Karen E Weck; Jay L Hess; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.

Authors:  Kazuhiko Hayashi; Zaishun Jin; Sachiyo Onoda; Hiromasa Joko; Norihiro Teramoto; Nobuya Ohara; Wakako Oda; Takehiro Tanaka; Yi-Xuan Liu; Tirtha Raj Koirala; Takashi Oka; Eisaku Kondo; Tadashi Yoshino; Kiyoshi Takahashi; Tadaatsu Akagi
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 9.  Primary pulmonary Hodgkin's lymphoma and a review of the literature since 2006.

Authors:  Nathania Cooksley; Daniel James Judge; James Brown
Journal:  BMJ Case Rep       Date:  2014-04-07

10.  Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma.

Authors:  Z Zeng; S Fan; X Zhang; S Li; M Zhou; W Xiong; M Tan; W Zhang; G Li
Journal:  Clin Transl Oncol       Date:  2015-08-11       Impact factor: 3.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.